2022 American Transplant Congress
Living Related Kidney Donation for Alternative Complement Pathway Diseases: Long-Term Outcomes
*Purpose: Atypical hemolytic-uremic syndrome (aHUS) and C3 glomerulopathy (C3G) are rare conditions that cause severe kidney disease. Data to guide the evaluation of living related…2022 American Transplant Congress
Landscape of Attitudes Towards Living Kidney Donation During the SARS-CoV-2 Pandemic in the United States: Results of a Public Opinion Survey
*Purpose: Solid organ transplantation decreased during the SARS-CoV-2 pandemic largely due to temporary shutdowns. The pandemic revealed significant gaps in medical knowledge among the public;…2022 American Transplant Congress
Outcomes of Living Liver Donors Are Worse Than Those of Matched Healthy Controls: Nationwide Cohort Study
*Purpose: Donor death is the most serious complication of living liver donation, but is reported rarely. We investigated the actual mortality of living liver donors…2022 American Transplant Congress
Performance of Updated Estimated Glomerular Filtration Rate Equations in Black Living Kidney Donor Candidates
Cleveland Clinic, Cleveland, OH
*Purpose: New estimated glomerular filtration rate (eGFR) equations using serum creatinine (Cr) and/or cystatin C (CysC) have been derived to eliminate adjustment by perceived Black…2022 American Transplant Congress
Experience with the First Two Living Donor Robotic Left Lobe Hepatectomies in the USA
Transplant, Lahey Clinic, Burlington, MA
*Purpose: Robotic living donor has been performed in a few centers with good outcomes; the first report of a robotic right lobe donor hepatectomy was…2022 American Transplant Congress
Utilizing Online Training Modules and Flowcharts to Maintain Regulatory Compliance with Abo Verification and Organ Check-In Procedures
*Purpose: Meeting the regulatory requirements for ABO Verification and solid Organ Check-In procedures is a constant challenge for transplant programs due to continuous turnover in…2022 American Transplant Congress
Clinical Relevance of Class II HLA Mismatches in Living Donor Kidney Transplantation
*Purpose: The benefit of class II HLA matching is primarily shown in deceased donor kidney transplantation. The objective of this study was to determine the…2022 American Transplant Congress
Factor V Leiden Heterozygosity and Live Donor Liver Donation – A Single Center Analysis
Thomas E Starzl Transplant Institute, University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: Living donor liver transplantation (LDLT) accounts for only a small percentage (< 6%) of all liver transplants performed for adult recipients in the western…2022 American Transplant Congress
Donor App Increases Awareness and Overall Rates of Living Kidney Donation
*Purpose: The rate of living donor kidney transplants (LDKTs) performed has declined overall regardless of race. Studies show that web-based tools increase access to living…2022 American Transplant Congress
Adult-to-Adult Living Donor Liver Transplantation in Acute Liver Failure – Do Outcomes Justify the Risks?
*Purpose: Living-donor Liver Transplantation(LDLT) has emerged as a safe and effective alternative in children and adults with pre-existing liver diseases. Utilization of LDLT for patients…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 27
- Next Page »